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 Abstract
In the past decade, interest and knowledge in the role of estrogen in male reproduction and fertility has 
gained significant momentum. More recently, the cellular distribution and activity of estrogen receptors 
(a and ß)(ER) and aromatase (estrogen synthesis) has been reported in the penis, making the penis the 
latest “frontier” in the study of estrogen in male reproduction. ER and aromatase are broadly and 
abundantly expressed in various penile compartments and cell types (erectile
tissues, urethral epithelia, vascular and neuronal cells), suggesting the complexity and significance of the 
estrogen-ER system in penile events. Unraveling this complexity is important and will require 
utilization of the various resources that are now at our disposal including, animal models and human 
lacking or deficient in ER and aromatase and the use of advanced and sensitive techniques. Some of the 
obvious areas that require our attention include: 1) a comprehensive mapping of ER-a and -ß cellular 
expression in the different penile compartments and subpopulations of cells, 2) delineation of the 
specific roles of estrogen in the different subpopulations of cells, 3) establishing the
relationship of the estrogen-ER system with the androgen-and rogen receptor system, if any, and 4) 
characterizing the specific penile phenotypes in human and animals lacking or deficient in estrogen and 
ER. Some data generated thus far, although preliminary, appear to challenge the long held dogma that, 
overall, androgens have a regulatory monopoly of penile development and function.
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Introduction 
Over half a century ago, the first report documenting 
synthesis of estrogen by male gonads was published 
(Zondek 1934; Goldzieher and Roberts 1952; Leach et 
al., 1956; Morse et al., 1962; Attal, 1969; Carreau et al., 
1999). However, interest in estrogen’s role in male 
reproductive events only began to gain momentum in the 
past decade, largely catapulted by the unexpected data 
generated by studies from: 1) male transgenic mice 
lacking functional estrogen receptors (ERs), aromatase 
or over-expressing aromatase, 2) newly discovered 
mutations in ER-and aromatase in human, and 3) from 
reports that exposure to environmental estrogens may 
have detrimental effects on male reproductive 
development and health (Greene et al., 1939; Stillman 
1982; Sharpe and Skakkebaek, 1993; Korach, 1994; 
Smith et al., 1994; Eddy et al., 1996; Krege et al., 1998; 
Carreau et al. 1999; Couse and Korach, 1999; McKinnell 
et al., 2001; Simpson, 2003, 2004; Hewitt et al., 2004). 
Clearly, based on these emerging evidences, estrogen 
exerts important influence on male reproductive events. 
Estrogen, which in the male is mainly produced by 
the testis and, to a lesser extent, by the brain and adrenal 
gland, exerts its effects on male reproduction via its 
receptors, estrogen receptors (ERs) that have been 
localized in the gonads, reproductive tract, accessory 
glands (Hess et al., 1997a,b, 2000; Mowa and Iwanaga, 
2001) and, more recently, in the male external genitalia, 
the penis (Jesmin et al., 2002; Crescoli et al., 2003; 
Dietrich et al., 2003; Goyal et al., 2004). The present 
review provides a general update on the emerging data 
of the latest ‘frontier’ in the study of estrogen’s action on 
male reproduction, the penis, including, 1) the 
distribution pattern of ER and aromatase, 2) the effects 
of ER and estrogen deficiency and excess on penile 
development and structure, and 3) the likely role of 
estrogen on penile events. 
An overview of penis development and structure 
Development 
The development of the external genitalia can be 
divided into two stages: 1) initial appearance of the 
genital tubercle, which is common to both sexes, and 2) 
the differentiation and growth of the genital tubercle into 
the penis (male) and clitoris (female) (Jirasek, 1971; 
Guthrie et al., 1973). Although the exact molecular 
mechanisms that underlie the development of external 
genitalia are unclear, the later phase of development, i.e, 
differentiation and growth, appear to be regulated by a 
delicate and complex balance between estrogen and 
androgen (Jirasek, 1971). In the human, prior to the 9th 
week of gestation, the external genitalia is indifferent 
(Jirasek, 1971), and the primordial fetal penis and 
clitoris are of equal size up until the 14th week of 
pregnancy (Jirasek, 1971). The 12-14th weeks of fetal 
life constitute a critical window of development because 
a shift in equilibrium between androgens and estrogens 
may lead to the development of hypospadia, failure of 
scrotal folds and pseudohermaphroditisia (see review 
Murray et al., 2001). However, the mechanisms or 
factors that underlie the development of the genital 
tubercle, which consists of formations and initial 
outgrowth, are unclear. This initial phase of external 
genital development is not sex steroid hormone- 
dependent, but is regulated by distal urethral epithelia, 
which expresses several genes, including Fgf8, Fgf10, 
Msx1, Hoxd13 and Bmp4 (Murakami and Mizuno, 
1986; Kondo et al., 1997; Mortlock and Innis, 1997; 
Haraguchi et al., 2000). 
The onset of masculanization of the male external 
genitalia coincides with Leydig cell-derived androgen 
production and absence of androgen in female fetus 
leads to passive development of the external genitalia 
(Jost, 1953; see review Hiort and Holterhus, 2000, 
2003). The role of estrogen in this process is unclear. 
Structure 
General structure 
The penis is a pendulous organ hinged to the pubic 
arch and is composed of two major components: 1) three 
columns of erectile tissues are divided into a paired 
corpora cavernosa and a corpus spongiosum, which are 
both covered by the tunica albiginea, and 2) the glans 
penis. The paired corpora cavernosa are laterally located 
along the dorsal body and the corpus spongiosus is 
located medially on the lower portion and has a urethra 
that passes through it. Regionally, the penis can be 
divided into 3 parts, namely: a) the root, anchored to the 
pubic arch, b) the body, forming the central and largest 
portion and, c) the glans, which is the most distal and 
expanded extremity. 
General vasculature 
The vasculature of the penis plays a very important 
role in erection. Arterial: The complex terminal arterial 
network of the common penile artery is supplied by the 
internal pudendal artery, a branch of the hypogastric 
artery. The common penile artery divides into the dorsal, 
cavernosus and bulbourethral arteries that either directly 
supply the cavernosus space or branch into the 
convulated helicine ateries, which ultimately open into 
the cavernosus spaces. The walls of these spaces are 
Fig. 1. Model illustrating the molecular anatomy of estrogen receptor 
(ER) subtypes and ß, divided into four structurally distinct functional 
domains: the N-terminal A/B region, containing activation function 1 (AF- 
1); the C- or DNA-binding domain (DBD); the hinge region or D domain; 
and the C terminus– or ligand-binding domain (LBD), which contains a 
ligand-binding pocket and sites for cofactor binding, transactivation (AF- 
2), nuclear localization, and interactions with heat shock protein 
complex. Numbers in the upper and lower panels represent the number 
of amino acids in ER-and ER-ß subtypes, respectively. The numbers 
in the middle panel represent percentage of homology between the 
specific domains of each ER subtype. [Reprinted from Mowa and 
Papka, 2004 The Role of Sensory Neurons in Cervical Ripening: Effects 
of Estrogen and Neuropeptides. J. Histochem. Cytochem. Volume 
52(10): 1249-1258, 2004, Histochemical Society]. 
Fig. 2. Schematic diagram of the ER and its mechanism of action in a 
model cell such as a sensory neuron. Estrogen diffuses into the cell and 
binds to the ER to initiate ER activation and dimerization (homo- and 
heterodimers). The ligand receptor complex in turn binds to the estrogen 
response elements on the promoter of the DNA to initiate transcription, 
translation, and, ultimately, cellular response. Rapid response to 
estrogen may be mediated by the recently described membrane ER 
(ER-X). [Reprinted from Mowa and Papka, 2004 The Role of Sensory 
Neurons in Cervical Ripening: Effects of Estrogen and Neuropeptides. J 
Histochem Cytochem, Volume 52(10): 1249–1258, 2004 by 
Histochemical Society]. 
formed by trabeculae, made of thick bundles of smooth 
muscles and collagen material and, peripherally, they are 
lined by vascular endothelial cells. Venous: The blood 
from cavernous spaces is drained by a series of 
subtunical veinous plexus that “pierce” through the 
tunica albiginea as emissary veins to form the circumflex 
veins, which in turn converge dorsally into the deep 
dorsal veins. Other draining veins include periurethral, 
crural and cavernosal. Collectively, these veins drain 
into the urethral vein that supplies the internal pudendal 
vein (Fernandez et al., 1991). 
General innervation 
The penis is richly innervated by the sympathetic, 
parasympathetic (autonomic), sensory and motor 
(somatic) nerves. The sympathetic and parasympathetic 
converge to form the cavernosus nerves that innervate 
the columnal erectile tissues (cavernosus and 
spongiosus) and largely modulate neurovascular events 
associated with erection and detumescence. On the other 
hand, the somatic nerves are largely involved in 
regulating sensation and contraction of the crural 
muscles (Mowa and Papka, 2003; El-Sakka and Lue, 
2004). 
Biology of estrogen receptor and synthesis 
Estrogen receptors 
Estrogen’s effects are principally mediated by two 
estrogen receptor (ER) subtypes, ER-, the “classical” 
subtype cloned in 1986 (Koike et al., 1987) and ER-ß, a 
more recently cloned subtype (Kuiper et al., 1996) (Fig. 
1). Different isoforms of ER-ß have since been 
identified, including ER-ß2, ER-ßcx, and ER-ß variants 
that are altered by a deletion within the DNA binding 
domain (ER-ß13 and ER-ß23) (Moore et al., 1998; 
Ogawa et al., 1998). 
ERs belong to the steroid/retinoid receptor 
superfamily that has structural and functional similarities 
(Mangelsdorf et al., 1995). They (ERs) are divided into 
four structurally distinct, functional domains: 1) the N- 
terminal A/B region, which has the activation function 1 
(AF1) that regulates transcriptional activation, 2) the C 
region (mid region) or DNA binding domain (DBD) that 
mediates specific DNA binding, 3) the less known D 
domain or hinge region, 4) the C terminus or ligand 
binding domain (LBD) containing the ligand binding 
pocket and sites for cofactor binding, transactivation 
(AF2), nuclear localization and interactions with heat 
Fig. 3. Immunohistochemistry for ER and AR in human 
fetal penile tissue. Transverse sections of human male 
external genitalia (MEG) of a fetus at the 12th week of 
gestation. White arrows indicate the forming male 
urethra (UR); black arrowheads in the glans stroma 
(GS) indicate the condensing connective tissue of the 
forthcoming CC. Note the inner prepuce (IP) 
surrounding the forming CC. A and B. Low 
magnification of the MEG. Immunostaining for ER- 
positive (A) and AR-positive (B) cells was present in 
several portions of the MEG, including the skin (circle), 
the UR, and the GS. Positivity for both sex steroid 
receptors occurred apparently in the same structures. C 
and D. Panels correspond to A and B, respectively. 
Note that blood vessels (black arrows) surrounding and 
invading the CC are positive for ER and AR. Stromal 
cells of the UR were also stained. E. ER 
immunostaining at the level of the prepuce showing 
positive endothelial and smooth muscle cells. F. 
Negative control avoiding primary antibodies. A and B, 
x 80; C-F, x 150. [Reprinted from Crescioli et al., 
Expression of functional estrogen receptors in human 
fetal male external genitalia. J Clin Endocrinol Metab, 
88 (4):1815-1824, with permission from The Endocrine 
Society]. 
shock proteins (see review; Weihua et al., 2003) (Fig. 1). 
Upon binding to its receptors, the ERs dimerize and 
control transcription by binding, in most cases, to the 
classical consensus estrogen response elements (ERE) in 
the promoter region of the target genes, leading to a 
cellular response (Fig. 2) (see review; Weihua et al., 
2003). Alternatively, ER can induce transcription by 
binding to AP-1 and Sp-1, where ER-and ER-ß have 
different, and in some cases, opposing effects (Phillips et 
al., 1993; Umayahara et al., 1994; Webb et al., 1995). 
Rapid effects of estrogen on neurons are exerted via the 
recently identified, but less characterized, membrane 
estrogen receptor (McEwen, 1991), which may be 
identified as ER-X (Toran-Allerand et al., 2002). 
Estrogen synthesis 
Estrogens, 17ß-estradiol and estrone, are produced 
from C19 androgens, testosterone and androstanedione, 
respectively, by cytochrome P450 arom (P450arom), a 
product of CYP19 gene. P450arom is a mono-oxygenase 
microsomal enzyme complex present in endoplasmic 
reticulum that irreversibly converts the aromatizable C19 
androgens to estrogens through 3 consecutive 
hydroxylation reactions at the A-ring (Lephart 1996; 
Pereyra-Martinez et al. 2001; Carreau et al. 2002; 
Wiszniewska 2002). Aromatase is expressed in a tissue- 
specific manner and is composed of two proteins, 
namely, 1) a ubiquitous NADPH-cytochrome P450 
Fig. 4. In situ hybridization analysis showing gene 
expressions of ERa in the rat penis. A. Distinct ER
mRNA signals were seen in the mesenchyme of the 
developing penis at fetal d 17. B–E. The transverse 
sections of the primordial penis exhibited more 
pronounced signals of ER mRNA in the proximal 
portion (left arrow in panel Bi) than the distal region (right 
arrow in panel Bi) at postnatal d 3. Urethral epithelium, 
especially the basal epithelium (be), and penile 
spongiosus (ps) of the proximal penis were more 
strongly labeled than those of the distal penis (D) (pc, 
penile cavernosus; u, urethral lumen). C and D are 
higher magnifications (x 400) of B, whereas Bi and Bii 
are bright-field and dark-field images, respectively. Ei 
and Eii are also bright- and dark-field images of the 
transverse section of the penis at postnatal d 7 taken at 
a more rostral or cranial position. F. No grain (ER 
mRNA signal) was observed in the transverse section of 
the penis at postnatal d 3 when excessive cold probe 
was added to a little amount of the corresponding hot 
probe during the hybridization process. G-H. The 
stratified epithelia of the middistal penile urethra at 
postnatal d 2 (G) and 14 (H) showed significant signals 
of ERa mRNA in the basal epithelial layer (be). Strong 
ERa mRNA signals in the spongiosus (ps) were seen at 
postnatal d 2 (G), which declined at postnatal d 14 (H). I. 
Distinct and intense signals of ER mRNA were 
localized to the lamellated sensory corpuscles (sc) of the 
glans penis at postnatal d 24. J. Immunohistochemical 
detection for S100 protein. Positive staining (brown) was 
found in the lamellated sensory corpuscles (sc). K. 
Immunohistochemical detection for active caspase 3, a 
member of caspase superfamily,  which init iates 
apoptotic events. Positive staining (brown) was found in 
the lamellated sensory corpuscles (sc). x 200 (x 100 for 
B, E, and F). [Reprinted from Jesmin et al. Evidence for 
a potential role of estrogen in the penis: Detection of 
estrogen receptor-and -ß messenger ribonucleic acid 
and protein. Endocrinology, December 2002, 
143(12):4764–4774, with permission from The Endocrine 
Society]. 
reductase and 2) a cytochrome P450 aromatase, which 
contain the heme and the steroid pocket (Lephart 1996; 
Carreau et al. 1999, 2002). 
Distribution of ER and aromatase in the penis 
Estrogen receptors 
The earliest evidence implicating estrogen in penile 
events emerged from human and, later, laboratory and 
wildlife studies several decades ago (see review Toppari 
et al., 1996). It was shown that exposure of male 
offspring to estrogen-like endocrine disruptors in utero 
induce micropenis and hypospadia (Toppari et al., 1996). 
However, in order to understand the effects of estrogen 
and the specific mechanisms underlying its action on 
penile events, it was essential to demonstrate presence of 
ER, the principal mediator of estrogen action. Indeed, 
the earlier data that implicated estrogen-like endocrine 
disruptors in penile development, served as the impetus 
to the subsequent ER distribution studies. However, the 
failure of the initial study to localize ER in fetal human 
corpus cavernosus by Kalloo et al. (1993) using 
immunohistochemistry, may have dampened interest in 
this field, until very recently in the early 2000s, 
following the first report by Jesmin and others (2002), 
which was shortly confirmed by others (Crescioli et al., 
2003; Dietrich et al., 2004; Goyal et al., 2004). The 
recent success in demonstrating ER in penile tissues 
could, in part, be attributed to new advancement in 
technology with increased sensitivity. 
Prenatal 
ER is expressed in the developing penis, as early as 
the prenatal stage in both the rat and human fetuses 
(Jesmin et al., 2002; Crescioli et al., 2003) (Figs. 3, 4a). 
In the human, by the 12th week of gestation, the earliest 
age investigated, ER was expressed throughout the entire 
developing organ, including the skin, urethra, glans, 
stromal cells of corpus cavernosus, stromal cells under 
urethra, smooth muscle cells under the level of inner 
prepuce and the endothelial and smooth muscle cells of 
the blood vessels in the corpus cavernosus (Crescioli et 
al., 2003). More importantly, ER was co-localized with 
the androgen receptor (AR) (Crescioli et al., 2003). 
Subsequent cultures of fetal human penile smooth 
muscle cells when analyzed by RT-PCR, Western blot 
and immunohistochemistry demonstrated both ER 
subtypes, ER-and ER-ß mRNAs and proteins 
(Crescioli et al., 2003). In the rat, ER-mRNA was 
demonstrated by in situ hybridization in the 
mesenchyme of the undifferentiated penis by day 17 of 
gestation, the earliest age examined. There were no 
Fig. 5. Immunofluorescent findings for 
ERa in the rat penis. A. Penile ERa 
distribution in postnatal d 1 rat (low 
magnification, x 100). Positive staining 
(red) was found in the penis 
spongiosus (ps), urethra (u), and 
penis carvenosus (pc). B and C. 
Immunoreactivity was found in the 
penis spongiosus (ps) and penis 
carvenosus (pc) (high magnifications 
x 200, [inset, x 400]). D. Positive 
staining was also found in the sensory 
corpuscle (sc) of glans penis (x 400). 
E. Immunoreactivity was less in the 
neurovascular bundle of body penis 
(x 200). F and G. Positive staining 
was found in the urethra (u) and 
urethral gland (ug) (magnification, 
x100). H. No staining was observed in 
the penile spongiosus (ps) when 
peptide-adsorbed antibody was used 
(x 200). I. Primary antibody (data not 
shown) or secondary antibody (data 
presented) showed no 
immunoreactivity with the penile 
spongiosus (ps), indicating the 
specificity of the antibodies (x 400). 
[Reprinted   from   Jesmin   et   al. 
Evidence for a potential role of 
estrogen in the penis: Detection of estrogen receptor- and -ß messenger ribonucleic acid and protein. Endocrinology, December 2002, 
143(12):4764–4774, with permission from The Endocrine Society]. 
permission from The Endocrine Society]. 
Fig. 6. Immunofluorescenct findings 
for ERb in the rat penis. A. Penile 
ERß distribution in postnatal d 1 rat 
(low magnification, x 100). B and C. 
Immunoreactivity found in carvenosus 
(pc) of body penis much more strongly 
than in the penis spongiosus (ps) 
(high magnification, x 400). D. Positive 
staining was seen in the 
neurovascular bundle of body penis 
(x 200). E, Positive staining found in 
the penile artery of root penis (x 400). 
F. Positive staining found in urethra 
(u) (x 100). G. No staining was 
observed in the penile cavernosus 
(pc) when peptide-adsorbed antibody 
was used (x 400). H. Primary antibody 
(data not shown) or secondary 
antibody (data presented) showed no 
immunoreactivity with the penile 
cavernosus (pc), indicating the 
specificity of the antibodies (x 400). 
[Reprinted from Jesmin et al. 
Evidence for a potential role of 
estrogen in the penis: Detection of 
estrogen receptor-and -ß 
messenger ribonucleic acid and 
protein. Endocrinology, December 
2002,   143(12):4764–4774,   with 
Fig. 7. Immunohistological localization 
of ER (red) and ERß (green) in the 
rat ovary (A–C) and penis (D–L). A. In 
the adult female rat ovary, ERa was 
immunolocalized to thecal cells (t) and 
interstitial gland cells (i) but not to 
granulosa cells (g) of follicles (f). B. In 
the same ovary, ERb was 
predominantly detected in granulosa 
cells (g) of follicles (f). C. Intense ERß 
staining (C1) was detected in luminal 
epithelium and muscle cells of the 
oviduct (ov), whereas ER (C2) was 
expressed mainly in epithelium of the 
oviduct (ov). D. Immunofluorescence 
double labeling for ERand ERß in 1- 
d-old rat penis (low magnification, 
x 100). E and F. ERß was expressed 
more abundantly than ER in the 
penis spongiosus (ps) (high 
magnification, x 200 and x 400). G. 
Primary antibodies (data not shown) or 
secondary antibodies used for double 
labeling (data presented) showed no 
reactivity with the penile spongiosus 
(ps), indicating the specificity of the 
antibodies (x 400). H. Both of ERand 
ERß were present in the penis 
cavernosus (pc) (high magnification, 
x 400). I. ERwas more dominant in the urethra than ERß (x 100). J–L. ERß immunoreactivity was main in the neurovascular bundle, dorsal artery, 
and dorsal nerve (x 200 for J, x 400 for K and L). [Reprinted from Jesmin et al. Evidence for a potential role of estrogen in the penis: Detection of 
estrogen receptor-and -ß messenger ribonucleic acid and protein. Endocrinology, December 2002, 143(12):4764–4774, with permission from The 
Endocrine Society]. 
ER–mRNA signals in the epithelium and for ER-ß 
mRNA (Jesmin et al., 2002) (Fig. 4a). 
Postnatal 
By as early as neonatal period, the distribution 
pattern of ER in the rat was almost as widespread in a 
subpopulation of cell types as in human fetal penis: 
during the first week of birth, the corpus spongiosus, 
basal epithelia, stromal cells adjacent to the urethral 
epithelium and blood vessels expressed signals of both 
ER-and -ß mRNAs and proteins, as demonstrated by 
both in situ hybridization and immunohistochemistry 
(Jesmin et al., 2002) (Figs. 3-7). Signals for ER-in the 
rat penis were more discrete and intense compared to 
ER-ß, which were more diffuse and moderate (Jesmin et 
al., 2002). Additionally, ER-mRNA and protein were 
also revealed in the sensory corpuscles of the glans and, 
together with ER-ß, in neurovascular bundle and dorsal 
nerve (Jesmin et al., 2002). Double immunofluorescence 
of ER- and -ß in the penis of 1-d-old rat showed a 
predominant distribution of ER in the penis 
spongiosus, and a predominant distribution of ERß in the 
urethra and neurovascular bundle (including dorsal 
blood vessels and dorsal nerve) (Jesmin et al., 2002) 
(Fig. 7). The penis cavernosus appeared to express ER 
and ERß equally. In another study by Goyal et al. (2004) 
that exclusively used immunohistochemistry, ER-was 
largely negative in most rat corpus cavernosus cells of 
both immature and mature, and only weak to moderate 
and very weak in some cells of the tunica albuginea and 
fibroblasts of the intercrural stroma, respectively. This is 
in contrast to earlier observations reported in rats by 
Jesmin et al. (2002) and in human by Cresoli (2003), 
which showed a more widespread distribution of ER 
Fig. 8. Schematic diagram shows an overview distribution of ER in the 
penile tissues (glans penis, penis spongiosus, penis cavernosus, penile 
urethra). Bottom right, cross section of penis. 
(Figs. 3-7). However, the expression pattern of ER in the 
corpus spongiosus as described by Goyal et al. (2004) 
were overall consistent with those described by Jesmin 
et al. (2002) and Crescioli et al. (2003) (Fig. 8). 
Adulthood 
The only report on ER expression in the penile tissue 
Fig. 9. Immunoblot analysis for ER (A1) and ERß (B1) in the penile 
tissues of 1-, 8-, 35-wk-old rats (lanes 3-5). The ovary from the adult 
female rat (lane 1) was used as a positive control. No band was seen 
when the antibody had been pre-adsorbed with antigen. Lower panels 
(A2, B2) show changes in the blots for ERand ERß obtained from the 
penile tissues of 8-wk-old rats after vehicle treatment (lane 1), DES 
treatment (lane 2), DES+ICI treatment (lane 3), and ICI treatment (lane 
4) for 3 wk. [Reprinted from Jesmin et al. Evidence for a potential role of
estrogen in the penis: Detection of estrogen receptor- and -ß 
messenger ribonucleic acid and protein. Endocrinology, December 
2002, 143(12):4764–4774, with permission from The Endocrine 
Society]. 
of men was recently described by Dietrich and others 
(2004) using immunohistochemistry and is principally 
consistent with the pattern observed in adult rat, as well 
as the human fetal penis described earlier (Jesmin et al., 
2002; Crescioli et al., 2004) (Figs. 3-8). In men ER- 
and ER-ß are largely co-expressed in the smooth muscle 
cells and endothelia (sporadically) of corpora cavernosus 
and spongiosus, although ER-ß is predominant (Dietrich 
et al., 2004). Both ER subtypes are also expressed in the 
periurethral and urethra. In the rat, ER mRNA is 
localized in the basal region of the urethra and 
lamellated sensory corpuscles, but with slightly 
decreased intensity in the adult. ERß mRNA was more 
diffused and was expressed in penis cavernosus, urethral 
glands, blood vessels, and dorsal nerve of penile 
spongiosus (Jesmin et al., 2002). 
Aromatase 
Evidence of the ability of male gonads to produce 
estrogen was reported more than half a century ago. 
Estrogen in the male is also known to be produced by 
the brain and adrenal gland, although to a lesser extent 
(see review Carreau et al., 1999, 2002; Simpson, 2003). 
However, it is only very recently that evidence of 
aromatase presence, activity and cellular distribution in 
penile tissues have been reported (Jesmin et al., 2004; 
Vignozzi et al., 2004). The pattern of aromatase 
distribution during development and adulthood are 
overall comparable to that of ER, based on in situ 
hybridization and immunolabeling: aromatase is 
localized to the penis spongiosus, penis cavernosus, 
urethra, sensory corpuscle of glans penis, blood vessel, 
Fig. 10. A. Levels of aromatase in rat adult ovary and penises at 1, 8, 35 weeks (1W, 8W, 
35W) as determined by ELISA. B. Gene expression level of aromatase in the penile tissues 
of 1-, 8-, and 35-week-old rats and in the adult ovary which was used as a positive control 
tissue. Expression of aromatase mRNA was quantitatively evaluated by real-time PCR. C. 
Tissue levels of 17ß estradiol in rat adult ovary and rat penile tissues at 1, 8, and 35 weeks. 
The 17ß-estradiol level was determined by enzyme immunoassay. Data are means ± S.D. 
(n=6–7). *P=0·01 compared with the corresponding values obtained in the ovary. [Reprinted 
from Jesmin et al. Aromatase is abundantly expressed by neonatal rat penis but 
downregulated in adulthood. J. Mol. Endocrinol., 2004, 33, 343-359, with permission from 
The Society of Endocrinology]. 
Fig. 11. Effect of estrogen ablation in sexually mature, 
intact rabbits. Responsiveness of CC to OT was tested in 
untreated rabbits (A and B; F; n=6 in three separate 
animals) or in animals treated daily for 3 wk with letrozole 
(2.5 mg/kg; A; f; n =6 in three separate animals) or TAM 
(0.250 mg/kg; B; f; n =6 in three separate animals). 
Ordinate, Contractile activity, expressed as a percentage 
of the maximal response obtained with KCl (80 mM); 
abscissa, concentrations of oxytocin (nanomolar). Data 
were expressed as the mean ± SEM. *: P<0.05; **: 
P<0.01 (vs. control). [Reprinted from Vignozzi et al. 
Oxytocin receptor is expressed in the penis and mediates 
an estrogen-dependent smooth muscle contractility. 
Endocrinology, April 2004, 145 (4): 1823-1834, with 
permission from The Endocrine Society]. 
Fig. 12. Estrogens inhibit proliferation in hfPSMC. A. Twenty-four hour 
incubation with increasing concentrations of 17ß-estradiol [10-13 to 10-16 
mol/liter] resulted in a statistically significant decrease in hfPSMC 
proliferation rate with IC50 = 0.2±0.1 x 10-10 mol/liter. Ordinate: Cell 
number expressed as percentage of the control; abscissa: logarithmic 
scale of 17ß-estradiol molar concentrations. Data were expressed as 
the means ± SEM values obtained in six different experiments. 
*: P<0.001 vs. control (0 nM), Student’s t test for paired data. Inset: 
Immunocytochemistry in hfPSMC shows positivity for ER in cell nuclei 
(x 300). B. The inhibitory effect of 17ß- estradiol on hfPSMC was 
counteracted by a fixed dose of the antiestrogen tamoxifen (+Tam, 100 
nmol/liter). Data were expressed as the means ± SEM values obtained 
in three different experiments. *: P<0.01 vs. control (0 nM); °: P<0.005 
vs. Tam-treated. Student’s t test for unpaired data. [Reprinted from 
Crescioli et al., Expression of functional estrogen receptors in human 
fetal male external genitalia. J. Clin. Endocrinol. Metab. 88 (4):1815- 
1824, with permission from The Endocrine Society]. 
dorsal nerve and primordial os penis at postnatal day 1 
(Jesmin et al., 2004). 
Levels of ER and aromatase change with age: 
Jesmin and others (2002, 2004) have reported an age- 
dependent expression of ER and aromatase levels using 
a variety of techniques, including RT-PCR, Western blot, 
ELISA, RIA and in situ hybridization. ER was detected 
in 1-wk-old rat penis, but was barely detectable at 8 and 
35 wk of age (Jesmin et al., 2002) (Fig. 9). Although 
ERß was detected in all ages examined, it also tended to 
decrease like ER-with age (Jesmin et al., 2002) (Figs. 
9,10). However, this observation has not yet been 
confirmed by others. It is essential that a more thorough 
and comprehensive data on ER and aromatase 
distribution patterns during different ages and species be 
determined. 
Role of estrogen in penile events 
Although our knowledge on the physiological role of 
estrogen in penile development and function is 
beginning to surface, it is for the most part limited, 
unclear and in some cases is yet to be reproduced. Much 
of what we know about the effects of estrogen on penile 
events in human, wildlife and laboratory animals is 
largely based on in utero exposure to environmental 
estrogens or mega pharmacological doses of estradiol 
(McLachlan et al., 1975; Sharpe and Skakkebaek, 1993). 
The fact that estrogen receptors and aromatase are 
localized in a diverse subpopulation of penile cells, 
including neurons, epithelia, stroma, glandular cells, 
suggests that its function in the penis is likely to be cell- 
specific and complex (Jesmin et al., 2002, 2004; 
Crescioli et al., 2003; Dietrich et al., 2004; Goyal et al., 
2004; Vignozzi et al., 2004). 
Penile postorgasm flaccidity 
Oxytocin is released during male orgasm and is 
believed to participate in the ejaculatory process (Ogawa 
et al., 1980). In the human and rabbit, oxytocin receptors 
have been localized in the corpus cavernosus and in vitro 
studies in human and rabbit model of hypogonadotropic 
hypogonadism. These studies have shown that the 
oxytocin receptor mediates corpus cavernosus 
contractility under the influence of steroid hormone 
mileau (Vignozzi et al., 2004). Estrogen, but not 
testosterone, restores oxytocin responsiveness, an effect 
attenuated by aromatase and ER blockers, suggesting 
that estrogen, acting via ER and oxytocin, may be 
involved in penile postorgasm flaccidity (Vignozzi et al., 
2004) (Fig. 11). 
Effect of estrogen on penile growth 
When varying doses of estrogen were administered 
to smooth muscle cells of the human fetal corpus 
cavernosus in vitro, they exerted an anti-proliferative 
effects in a dose-dependent manner, an effect that was 
opposite to testosterone (Crescioli et al., 2003) (Fig. 12). 
This observation in human cells is consistent with the 
elegant in vivo data from rats by Goyal et al. (2004) and 
Yucel and others (2003) demonstrating an inhibitory 
effect of DES on rat penile growth and differentiation, 
and urethral closure, respectively (Figs. 13, 14). Taken 
together, these data, together with data from 
xenoestrogens, suggest that the balance between 
androgens and estrogen is critical in penile growth and 
differentiation. Exactly how estrogens and androgens 
and their respective receptors interact is unclear. 
However, it may be that some of the penile effects 
currently attributed to androgens, such as androgen 
receptor down-regulation (Takane et al., 1990), may be 
mediated by estrogens via aromatization of testosterone 
(Lin et al., 1993). 
Other potential roles of estrogen in the penis 
Based on the localization of ER in diverse penile 
compartments and cell subpopulations, estrogen likely 
plays a broad range of functions in the penis, which at 
this point are purely speculative. 
Blood vessel 
The presence of ER and aromatase in the blood 
vessel lining and walls in rat and human penile tissues 
suggests that estrogen may influence the penile 
vasculature, possibly, as is the case in other body tissues, 
by influencing synthesis of vascular chemical mediators 
such as NO and prostacyclin (Calles-Escandoon and 
Cipolla, 2001). Of interest to erection, estrogen may 
influence the erectile tissue in a rapid non-genomic and 
NO-independent mechanism, as reported recently by 
Kim and others (2004), by stimulating the Maxi-K 
channel of the cavernosus myocyte. 
Nerves 
ER and aromatase in the rat and human are localized 
to the penile nerves (Jesmin et al., 2002, 2004; Crescioli 
et al., 2003). The presence of ER-and aromatase in the 
rat sensory corpuscle of glans penis, containing the 
highest concentration of sensory nerve fibers vital for 
sexual sensation (Kandel et al., 2001), is interesting and 
intriguing, particularly because both ERand ERß have 
Fig. 13. Radiographs of the penis at 18, 41, and 120 
days of age in rats treated with oil (control) or DES 
neonatally. Note reductions in length and diameter of 
the body and glans of the penis, a reduction in 
thickness of the proximal part of the os penis (PO), and 
the lack of development of the distal part of the os 
penis (DO), as a result of treatment. Scale bar 5 1 cm. 
[Reprinted from Goyal et al. Abnormal morphology of 
the penis in male rats exposed neonatally to 
diethylstilbestrol is associated with altered profile of 
estrogen receptor-a protein, but not of androgen 
receptor protein: a developmental and 
immunocytochemical study. Biology of Reproduction, 
with permission from The Society for the Study of 
Reproduction]. 
 
 
 
 
been identified in neural circuits involving central 
neurons, autonomic and sensory ganglionic neurons, and 
spinal cord neurons in areas that have connections with 
the male reproductive systems (Taleghany et al., 1999; 
Burke et al., 2000; Murphy and Hoffman, 2001). 
Estrogen may likely be important in the survival and 
 
vitality of sensory corpuscles and, consequently, on 
sexual sensation. It is also important to note that the 
main efferent parasympathetic pathway supplies 
vasodilating innervation to the cavernosus bodies, 
whereas the main sympathetic pathway supplies mostly 
the vasoconstriction innervation, thus chiefly mediates 
 
 
 
 
 
 
Fig. 14. Micrographs from the 
body of the penis in control 
rats (A–D) and in rats treated 
with DES neonatally (E–H) at 
18 days of age. A, E. Note 
similarity in spatial 
arrangement of different parts 
of the body of the penis 
between control and treated 
rats: paired corpora 
cavernosa (CC), corpus 
spongiosus (CS), and 
intercrural septum (IC) 
containing blood vessels (BV) 
and nerves (N). B. Corpus 
cavernosus penis from the 
control rat showing tunica 
albuginea fibrous (TAF), 
tunica albuginea cellular 
(TAC), cavernous spaces 
(CS), and intercavernous 
septa (IC) containing fibers, 
stromal fibroblasts,  and 
smooth muscle cells (arrows) 
under the endothelium of 
cavernous spaces. F. 
Conversely, in the corpus 
cavernosum penis of the 
treated rat, note absence of 
cavernous spaces, 
decreased thickness of tunica 
albuginea (TA), and 
increased deposition of 
empty-appearing fat cells (*). 
C and G. Epoxy sections of 
the corpus cavernosum from 
the control and treated rats. 
Note increased deposition of 
fat cells in the treated rat; 
cavernous spaces (CS), 
tunica albuginea (TA), small 
arteriole (arrow). D and H. In 
these low-magnif ication, 
unparaffinized sections of the 
body of the penis, note much 
higher accumulation of fat 
cells in the corpora 
cavernosa penis of the 
treated rat. A, B, E, and F. 
Hematoxylin and eosin, (C 
and G) toluidine blue, (D and 
H) fat stain. Scale bars: A, D, 
E, and H, 100 mm; B, C, F, and G, 30 mm. [Reprinted from Goyal et al. Abnormal morphology of the penis in male rats exposed neonatally to 
diethylstilbestrol is associated with altered profile of estrogen receptor-a protein, but not of androgen receptor protein: a developmental and 
immunocytochemical study. Biology of Reproduction, with permission from The Society for the Study of Reproduction]. 
detumescence (Kandel et al., 2001). 
Finally, it is interesting to note that levels of ER, 
together with AR and progesterone receptor (PR) are 
down-regulated in the penile crura of aging rats and are 
associated with aging-related erectile dysfunction (Shirai 
et al., 2003). 
Effect of xenoestrogens, knockout and mutation of 
aromatase and ER on the penis 
Xenoestrogens 
As stated above, interest in the role of estrogen in 
penile events was, to a large measure initiated by reports 
that in utero exposure of male offspring (human, 
laboratory and wildlife) to estrogen-like endocrine 
disruptors (EED) induce micropenis (McLachlan et al., 
1975; Raman-Wilms et al., 1995; Visser et al., 1998). 
Subsequent studies reported that mothers with 
significant intake of foods rich in estrogens 
(phytoestrogen) were more likely to give birth to boys 
with hypospadia (see North and Golding, 2000). Other 
EED, such as the estrogen antagonist tamoxifen, when 
given to neonatal rats permanently disrupts 
differentiation of os penis and completely erases 
epidermal projections and keratinization of the glans 
penis (Iguchi et al., 1990; Deveci et al., 1997). Clearly, 
taken together, these data strongly point to the presence 
of an estrogen system in the penis. However, the specific 
mechanisms underlying the effects of EED on penile 
development are unclear. 
Human mutations and Knockout animal models of 
aromatase and ER 
Data obtained from studies of animal models lacking 
ER and aromatase and men with mutations of these 
genes, have greatly enhanced our understanding of the 
functional significance of estrogen and its receptors in 
male fertility (Korach, 1994; Smith et al., 1994; 
Morishima et al., 1995; Eddy et al., 1996; Carani et al., 
1997, 1999; Bilezikian et al., 1998; Fisher et al., 1998; 
Krege et al., 1998; Faustini-Fustini et al., 1999; Li et al., 
2001; Rochira et al., 2001). However, the effects of these 
mutations and gene deletions or over-expressions on the 
penile events have not been adequately addressed. Based 
on the distribution and abundance of ER and aromatase 
in the developing penis and the inhibitory effects of EED 
on penile growth, one would expect that a lack or 
deficiency of aromatase and or ER in animal models and 
human, respectively, would lead to enhanced penile 
growth or size. To the contrary, and surprisingly, the 
preliminary data, thus far, report normal development of 
the male external genitalia in men, suggesting that 
estrogen and ER are not important regulators of penile 
development and growth (Morishima et al., 1995; Carani 
et al., 1997, 1999; Bilezikian et al., 1998; Faustini- 
Fustini et al., 1999). There is need to undertake detailed 
and systematic investigations using the available animal 
models in order to address these discrepancies.  
Additionally, and of equal importance, it is essential to 
investigate whether deficiency or deletion of the 
estrogen-ER system influence the androgen-AR system 
in the penis, as is the case in some areas of the brain 
(McAbee and DonCarlos, 1999). These studies should 
shed light on the extent or degree to which the two 
hormonal systems interact in regulating penile 
development and function. 
Conclusion 
The field of estrogen and ER in penile events is the 
latest ‘frontier’ in the study of estrogen in male 
reproduction. Although important findings are beginning 
to emerge, most of these findings need to be reproduced 
by other workers to arrive at a consensus. Secondly, 
there remains a lot of unanswered questions. The most 
notable questions include: 1) the interaction of the 
estrogen-ER system with the principal regulator of 
penile function, the androgen-AR system, 2) a more 
detailed cellular expression of ER- and -ß in the 
different penile compartments and subpopulations of 
cells in development, adulthood and in different species, 
3) delineation of the specific functional roles of estrogen
in the different subpopulations of cells, 4) a more 
systematic and comprehensive study of the impact of 
lack or deficiency of estrogen and ER on penile events 
and on the androgen-AR system. Thus far, data emerging 
from various studies appear to suggest a role for 
estrogen in penile development and growth. These data 
may challenge the long held dogma that androgens are 
the sole regulators of penile development and function. 
References 
Attal J. (1969). Levels of testosterone, androstenedione, estrone and 
oestradiol-17ß in the testes of fetal sheep. Endocrinology 85, 280- 
289. 
Bilezikian J.P., Morishima A., Bell J. and Grumbach M.M. (1998). 
Increased bone mass as a result of estrogen therapy in a man with 
aromatase deficiency. N. Engl. J. Med. 339, 599-603. 
Burke K.A., Schroeder D.M., Abel R.A., Richardson S.C., Bigsby R.M. 
and Nephew K.P. (2000). Immunohistochemical detection of 
estrogen receptor a in male rat spinal cord during development. J. 
Neurosci. Res. 61, 329-337. 
Calles-Escandon J. and Cipolla M. (2001). Diabetes and endothelial 
dysfunction: a clinical perspective. Endocr. Rev. 22 36-52. 
Carani C., Qin K., Simoni M., Faustini-Fustini M., Serpente S., Boyd J., 
Korach K.S. and Simpson ER (1997). Effect of testosterone and 
estradiol in a man with aromatase deficiency. N. Engl. J. Med. 337, 
91-95. 
Carani C., Rochira V., Faustini-Fustini M., Balestrieri A. and Granata 
A.R.M. (1999). Role of estrogen in male sexual behaviour: insights 
from the natural model of aromatase deficiency. Clin. Endocrinol. 51, 
517-525. 
Carreau S., Genissel C., Bilinska B. and Levallet J. (1999). Sources of 
oestrogen in the testis and reproductive tract of the male. Int. J. 
Androl. 22, 211-223. 
Carreau S., Bourguiba S., Lambard S., Galeraud-Denis I., Genissel C. 
and Levallet J. (2002). Reproductive system: aromatase and 
estrogens. Mol. Cell. Endocrinol. 193, 137-143. 
Couse J.F. and Korach K.S. (1999). Estrogen receptor null mice: what 
have we learned and where will they lead us? Endocr. Rev. 20, 358- 
417. 
Crescioli C., Maggi M., Vannelli G.B., Ferruzzi P., Granchi S., Mancina 
R., Muratori M., Forti G., Serio M. and Luconi M. (2003). Expression 
of functional estrogen receptors in human fetal male external 
genitalia. J. Clin. Endocrinol. Metab. 88, 1815-1824. 
Deveci E., Onen A., Tacar O. and Yildrim A. (1997). The effect of 
tamoxifen on the neonatal development of the rat glans penis. Clin. 
Exp. Obstet. Gynecol. 24, 237-239. 
Dietrich W., Haitel A., Huber J.C. and Reiter W.J. (2004). Expression of 
estrogen receptors in human corpus cavernosus and urethra. J. 
Histochem. Cytochem. 52, 355-360. 
Eddy E.M., Washburn T.F., Bunch D.O., Goulding E.H., Gladen B.C., 
Lubahn D.B. and Korach K.S. (1996). Targeted disruption of the 
estrogen receptor gene in male mice causes alteration of 
spermatogenesis and infertility. Endocrinology 137, 4796-4805 
El-Sakka A.I. and Lue T.F. (2004). Physiology of penile erection. Sci. 
World J. 4 (Suppl 1), 128-134. 
Faustini-Fustini M., Rochira V. and Carani C. (1999). Oestrogen 
deficiency in men: where are we today? Eur. J. Endocrinol. 140, 
111-129. 
Fernadez E., Dail W.G., Walton G. and Martinez G. (1991). The 
vasculature of the rat penis: a scanning electron microscopic and 
histological study. Am. J. Anat. 192, 307-318. 
Fisher C.R., Graves K.H., Parlow A.F. and Simpson E.R. (1998). 
Characterization of mice deficient in aromatase (ArKO). because of 
targeted disruption of the cyp19 gene. Proc. Natl. Acad. Sci. USA 
95, 6965-6970. 
Goldzieher J.W. and Roberts I.S. (1952). Identification of oestrogen in 
the human testis. J. Clin. Endocrinol. Metab. 12, 143-150. 
Greene R., Burrill M. and Ivy A. (1939). Experimental intersexuality: 
modification of sexual development of the white rat with a synthetic 
estrogen. Proc. Soc. Exp. Biol. Med. 41, 169-170. 
Goyal H.O., Braden T.D., Williams C.S., Dalvi P., Mansour M.M., 
Mansour M., Williams J.W., Bartol F.F., Wiley A.A., Birch L. and 
Prins G.S. (2004). Abnormal morphology of the penis in male rats 
exposed neonatally to diethylstilbestrol is associated with altered 
profile of estrogen receptor- protein, but not androgen receptor 
protein: a developmental and immunochemical study. Biol. Reprod. 
70, 1504-1517. 
Guthrie R.D., Smith D.W. and Graham C.B. (1973). . Testosterone 
treatment for micropenis during early childhood. J. Pediat. 83, 247- 
252. 
Haraguch R., Suzuki K., Murakami R., Sakai M., Kamikawa M., 
Kengaku M., Sekine K., Kawano H., Kato S., Ueno N. and Yamada 
G. (2000). Molecular analysis of external genitalia formation: the role 
of fibroblast growth factor (Fgf) genes during genital tubercle 
formation. Development 127, 2471-2479. 
Hess R.A., Gist D.H., Bunick D., Lubahn D.B., Farrell A., Bahr J., Cooke 
P.S. and Greene G.L. (1997a). Estrogen receptor (, ß). expression 
in the excurrent ducts of the adult male rat reproductive tract. J. 
Androl. 18, 602-611. 
Hess R.A., Bunick D., Lee K.H., Bahr J., Taylor J.A., Korach K.S. and 
Lubahn D.B. (1997b). A role for estrogen in the male reproductive 
system. Nature 390, 509–512. 
Hewitt S.C., Harrell J.C. and Korach K.S. (2004). Lessons in estrogen 
biology from knockout and transgenic animals. Annu. Rev. Physiol. 
Sep. 28, 
Hiort O. and Holterhus P.M. (2000). The molecular basis of male sexual 
differentiation. Eur. J. Endocrinol. 142, 101-110. 
Hiort O. and Holterhus P.M. (2003). Androgen insensitivity and male 
infertility. Int. J. Androl. 26, 16-20. 
Iguchi T., Irisawa S., Uesugi Y., Kusunoki S. and Takasugi N. (1990). 
Abnormal development of the os penis in male mice treated 
neonatally with tamoxifen. Acta Anat. 139, 201–208. 
Jesmin S., Mowa C.N., Matsuda N., Salah-Eldin A-E., Togashi H., 
Sakuma I., Hattori Y. and Kitabatake A. (2002). Evidence for a 
potential role of estrogen in the penis: detection of estrogen 
receptor-a and-ß messenger ribonucleic and protein. Endocrinology 
143, 4764-4774. 
Jesmin S., Mowa C.N., Sakuma I., Matsuda N., Togashi H., Yoshioka 
M., Hattori Y. and Kitabatake A. (2004). Aromatase is abundantly 
expressed by neonatal rat penis but downregulated in adulthood. J. 
Mol. Endocrinol. 33, 343-359. 
Jirasek J.E. (1971). Development of the genital system and male 
pseudohermaphroditism. John Hopkins Press. Baltimore. 
Jost A (1953). Problems in fetal endocrinology: the gonadal and 
hypophyseal hormones. Recent Prog. Horm. Res. 8, 379-383. 
Kalloo N.B., Gearhart J. and Barrack E. (1993). Sexually dimorphic 
expression of estrogen receptors, but not of androgen receptors in 
human fetal external genitalia. J. Clin. Endocrinol. Metab. 77, 692- 
698. 
Kandeel F.R., Koussa V.K.T. and Swerdloff R.S. (2001). Male sexual 
function and its disorders, physiology, pathophysiology, clinical 
investigation, and treatment. Endocr. Rev. 22, 342-388. 
Kim S.C., Seo K.K., Myung S.C. and Lee M.Y. (2004). Relaxation of 
rabbit cavernous smooth muscle to 17ß-estradiol: a non-genomic, 
NO-independent mechanism. Asian J. Androl. 6, 127-131. 
Koike S., Sakai M. and Muramatsu M. (1987). Molecular cloning and 
characterization of rat estrogen receptor cDNA. Nucleic Acids Res. 
15, 2499-2513. 
Kondo T., Zakany J., Innis J.W. and Duboule D. (1997). Of fingers, toes 
and penises. Nature 390, 29. 
Korach K.S. (1994). Insights from the study of animals lacking functional 
estrogen receptor. Science 266, 1524-1527. 
Krege J.H., Hodgin J.B., Couse J.F., Enmark E., Warner M., Mahler 
J.F., Sar M., Korach K.S. and Gustafsson J.A. and Smithies O 
(1998). Generation and reproductive phenotypes of mice lacking 
estrogen receptor ß. Proc. Natl. Acad. Sci. USA 95, 15677-15682. 
Kuiper G.G.J.M., Enmark E., Pelto-Hnikko M., Nilssons amd Gustatsson 
J.A. (1996). Cloning of a novel estrogen receptor expressed in the 
rat prostate and ovary. Proc. Natl. Acad. Sci. USA 93, 5925-5930. 
Leach R.B., Maddock W.O., Tokuyama I., Paulsen C.A. and Nelson 
W.O. (1956). Clinical studies of testicular hormone production. 
Recent. Prog. Horm. Res. 12, 377-397. 
Lephart E.D. (1996). A review of brain aromatase cytochrome P450. 
Brain Res. Rev. 22 1–26. 
Lin M.C., Rajfer J., Swerdloff R.S. and Gonzalez-Cadavid N.F. (1993). 
Testosterone down-regulates the levels of androgen receptor mRNA 
in smooth muscle cells from the rat corpora cavernosa via 
aromatization to estrogens. J. Steroid Biochem. Mol. Biol. 45 333- 
343. 
Li X., Nokkala E., Yan W., Streng T., Saarinen N., Warri A., Huhtaniemi 
I., Santti R., Makela S. and Poutanen M. (2001). Altered structure 
and function of reproductive organs in transgenic male mice 
overexpressing human aromatase. Endocrinology 142, 2435-2442. 
Mangelsdorf D.J., Thummel C., Beato M., Herrlich P., Schutz G., 
Umesono K. and Blumberg B. (1995). The nuclear receptor 
superfamily: the second decade. Cell 83, 835-839. 
McAbee M.D. and Doncarlos L.L. (1999). Estrogen, but not androgens, 
regulates androgen receptor messenger ribonucleic acid expression 
in the developing male rat forebrain. Endocrinology 140, 3674-3681. 
McEwen B.S. (1991). Non-genomic and genomic effects of steroids on 
neural activity. Trends Pharmacol. Sci. 12, 141-147. 
McLachland J.A., Newbold R.R and Bulock B. (1975). Reproductive 
tract lesions in male mice exposed prenatally to diethylstilbestrol. 
Science 190, 991-992. 
McKinnell C., Atanassova N., Williams K., Fisher J.S., Walker M., 
Turner K.J., Saunders P.T.K. and Sharpe R.M. (2001). . 
Suppression of androgen action and the induction of gross 
abnormalities of reproductive tract in male rats treated neonatally 
with diethylstibestol. J. Androl. 22, 323–338 
Meistrich M.L., Hughes T.J. and Bruce W.R. (1975). Alteration of 
epididymal sperm transport and maturation in mice by oestrogen 
and testosterone. Nature 258, 145-147. 
Moore J.T., McKee D.D., Slenz-Kesker K., Moore L.B., Jones S.A., 
Horne E.L., Su J.L., Kliewer S.A., Lehmann J.M. and Wilson T.M. 
(1998). Cloning and characterization of human estrogen receptor ß 
isoforms. Biochem Biophys Res Commun 247, 75-78. 
Morishima A., Grumbach M.M., Simpson E.R., Fisher C. and Qin K. 
(1995). Aromatase deficiency in male and female sibling caused by 
a novel mutation and the physiological role of estrogens. J. Clin. 
Endocrinol. Metab. 80, 3689-3699. 
Mortlock D.P. and Innis J.W. (1997). Mutation of HOXA13 in hand-foot- 
genital syndrome. Nat. Genet. 15, 179-180. 
Morse W.I., Clark A.F., MacLeod S.C., Ernst W.A. and Grossee C.L. 
(1962). Urine oestrogen responses to human chorionic gonadotropin 
in gonad of old and hypogonadal men. J. Clin. Endocrinol. Metab. 
22, 678-685. 
Mowa C.N. and Iwanaga T. (2001). Expression of estrogen receptor-
and -000ß mRNAs in the male reproductive system of the rat as
revealed by in situ hybridization. J. Mol. Endocrinol. 26, 165–174. 
Mowa C.N. and Papka R.E. (2003). The genital sensory system. In: 
Encyclopedia of neuroscience. Adelman G. and Smith B. (eds). 
Third edition (CD-ROM). 
Murakami R. and Mizuno T. (1986). Proximal-distal sequence of 
development of the skeletal tissues in the penis of rat and the 
inductive effect of epithelium. J. Embryol. Exp. Morphol. 92, 133- 
143. 
Murray T.J., Lea R.G., Abramovich D.R., Haites N.E. and Fowler P.A. 
(2001). Endocrine disrupting chemicals: effects on human male 
reproductive health. Early Pregnancy V 80-112. 
Murphy A.Z. and Hoffman G.E. (2001). Distribution of gonadal steroid 
receptor-containing neurons in the preoptic-periaqueductal gray- 
brainstem pathway: a potential circuit for the initiation of male sexual 
behavior. J. Comp. Neurol. 438, 191-212. 
North K. and Golding J. (2000). A maternal vegetarian diet in pregnancy 
is associated with hypospadias. The ALSPAC Study Team. Avon 
longitudinal study of pregnancy and childhood. Br. J. Urol. Int. 85, 
107-113. 
Ogawa S., Kudo S., Kitsunami Y. and Fukuchi S. (1980). Increase in 
oxytocin secretion at ejaculation in male. Clin. Endocrinol. 13, 95-97. 
Ogawa S., Inoue S., Watanabe T., Orimo A., Hosoi T., Ouchi Y. and 
Muramatsu M. (1998). Molecular cloning and characterization of 
human estrogen receptor bcx: a potential inhibitor of estrogen action 
in human. Nucleic Acids Res. 26, 3505-3512. 
Pereyra-Martinez A.C., Roselli C.E., Stadelman H.L. and Resko J.A. 
(2001). Cytochrome P450 aromatase in testis and epididymis of 
male rhesus monkeys. Endocrine 16, 15-19. 
Philips A., Chalbos D. and Rochefort H. (1993). Estradiol increases and 
anti-estrogens antagonize the growth factor-induced activator 
protein-1 activity in MCF7 breast cancer cells without affecting c-fos 
and c-jun synthesis. J. Biol. Chem. 268, 14103-14108. 
Raman-Wilms L., Lin-in Tseng A., Wighardt S., Einarson T.R. and 
Gideon K. (1995). Fetal genital effects of first trimester sex hormone 
exposure: a meta-analysis. Obstet. Gynecol. 85, 141-149. 
Rochira V., Balestrieri A., Madeo B., Baraldi E., Faustini-Fustini M., 
Granata A.R.M. and Carani C. (2001). Congenital estrogen 
deficiency: in  search of  the  estrogen role in human male 
reproduction. Mol. Cell Endocrinol. 178, 107-115 
Sharpe R.M. and Skakkebaek N.E. (1993). Are oestrogens involved in 
falling sperm counts and disorders of the male reproductive tract? 
Lancet 341, 1392-1395. 
Shirai M., Yamanaka M., Shiina H., Igawa M., Fujime M., Lue T.F. and 
Dahiya R. (2003). Downregulation of androgen, estrogen and 
progesterone receptor genes and protein is involved in aging-related 
erectile dysfunction. Int. J. Impot. Res. 15, 391-396. 
Shirai M., Yamanaka M., Shiina H., Igawa M., Fujime M., Lue T.F. and 
Dahiya R. (2003). Downregulation of androgen, estrogen and 
progesterone receptor genes and protein is involved in aging-related 
erectile dysfunction. Int. J. Impot. Res. 15, 391-396. 
Simpson E.R. (2003). Sources of estrogen and their importance. J. 
Steroid Biochem. Mol. Biol. 86, 225-230. 
Simpson E.R. (2004). Models of aromatase insufficiency. Semin. 
Reprod. Med. 22, 25-30. 
Smith E.P., Boyd J., Frank G.R., Takahashi H., Cohen R.M., Specker 
B., Williams T.C., Lubahn D.B. and Korach K.S. (1994). Estrogen 
resistance caused by a mutation in the estrogen-receptor gene in a 
man. N. Engl. J. Med. 331, 1056-1061. 
Stillman R.J. (1982). In utero exposure to diethylstilbesterol: adverse 
effects on the reproductive tract and reproductive performance of 
male and female offspring. American Journal of Obstetrics and 
Gynecol. 142, 905-921. 
Takane K.K., George F.W. and Wilson J.D. (1990). Androgen receptor 
of rat penis is down-regulated by androgen. Am. J. Physiol. 258, 
E46–E50. 
Taleghany N., Sarajari S., DonCarlos L.L., Gollapudi L. and Oblinger 
M.M. (1999). Differential expression of estrogen receptor and ß in 
rat dorsal root ganglion neurons. J Neurosci Res 57, 603-615. 
Toppari J., Larsen J.C., Christiansen P., Giwercman A., Grandjean P., 
Guillette L.J. Jr, Jegou B., Jensen T.K., Jouannet P., Keiding N., 
Leffers H., McLachlan J.A., Meyer O., Muller J., Rajpert-De Meyts 
E., Scheike T., Sharpe R., Sumpter J. and Skakkebaek N.E. (1996). 
Male reproductive health and environmental xenoestrogens. 
Environ. Health Perspect. 104 (Suppl 4), 741-803. 
Toran-Allerand C.D., Guan X., MacLusky N.J., Horvath T.L., Diano S., 
Singh M., Connolly E.S. Jr, Nethrapalli I.S. and Tinnikov A.A. (2002). 
ER-X: a novel plasma membrane-associated, putative estrogen 
receptor that is regulated during development and after ischemic 
brain injury. J. Neurosci. 22. 8391–8401. 
Umayahara Y., Kawamori R., Watada H., Imano E., Iwama N., 
Morishima T. and Yamasaki Y. (1994). Estrogen regulation of the 
 
 
 
 
insulin-like growth factor I gene transcription involves an AP-1 
enhancer. J. Biol. Chem. 269, 16433-16442. 
Webb P., Lopez G.N., Uht R.M. and Kushner P.J. (1995). Tamoxifen 
activation of the estrogen receptor/AP-1 pathway: potential origin for 
the cell-specific estrogen-like effects of antiestrogens. Mol. 
Endocrinol. 9, 443-456. 
Weihua Z., Andersson S., Cheng G., Simpson E.R., Warner M. and 
Gustafsson J.A. (2003). Update on estrogen signaling. FEBS Lett. 
546, 17–24. 
Wiszniewska B. (2002). Primary culture of the rat epididymal epithelial 
cells as a source of oestrogen. Andrologia 34, 180-187. 
Yucel S., Cavalcanti A.G., Desouza A., Wang Z. and Baskin L.S. (2003). 
The effect of oestrogen and testosterone on the urethral seam of the 
developing male mouse genital tubercle BJU Int. 92, 1016- 
 
1021. 
Vignozzi L., Filippi S., Luconi M., Morelli A., Mancina R., Marini M., 
Vannelli G.B., Granchi S., Orlando C., Gelmini S., Ledda F., Forti G. 
and Magg M. (2004). Oxytocin receptor is expressed in the penis 
and mediates an estrogen-dependent smooth muscle contractility. 
Endocrinology 145, 1823-1834. 
Visser J.A., McLuskey A., Verhoef-Post M., Kramer P., Grootegoed J.A. 
and Themmen A.P.N. (1998). Effect of prenatal exposure to 
diethylstilbestrol on Müllerian duct development in fetal male mice. 
Endocrinology 139, 4244-4251. 
Zondek B. (1934). Mass excretion of oestrogenic hormone in the urine 
of the stallion. Nature 193, 209-210. 
 
 
